Brendan Kosko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brendan Kosko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Ameer Tabbaa
Orlando Health Jewett Orthopedic Institute, FL, USA
1 shared publication- Benjamin C. Service
Orlando Health Jewett Orthopaedic Institute, Orlando, Florida
1 shared publication - Bradley Richey
University of Michigan Orthopaedic Surgery Residency Program, Ann Arbor, Michigan
1 shared publication - Brett Lewellyn
Orlando Health Jewett Orthopedic Institute, FL, USA
1 shared publication Bryan Brown
Orlando Health Jewett Orthopedic Institute, FL, USA
1 shared publication- D. Harrison Youmans
Rothman Orthopaedics Florida at AdventHealth, Orlando, Florida
1 shared publication
Latest Publications
- 10 May 2026
- Published by SAGE Publications in HAND
Timing of Tourniquet Release: A Prospective Randomized Trial
Background: Although the benefits and complications of tourniquet use are well-described, there has been minimal upper extremity research evaluating the timing of tourniquet release and how it affects patient outcomes. The objective of this study was to determine if tourniquet release prior to or after incision closure would affect clinical outcomes in a variety of upper extremity surgeries. Methods: Two hundred fourteen consecutive patients were randomized into 2 groups: skin incision closure without releasing the tourniquet versus skin closure following tourniquet release. Demographic, intraoperative, and follow-up data were collected. Outcome measures included complications such as hematoma formation, Visual Analogue Scores for pain, and Quick Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaires. Results: Two hundred fourteen patients were originally enrolled, with 172 available for follow-up. Ninety-one patients had the tourniquet released prior to incision closure and 81 patients had the tourniquet released after incision closure. Demographic data were similar between the 2 cohorts and there were no intraoperative or immediate postoperative complications requiring intervention in either group. In addition, follow-up data collected including visual analog scores and QuickDASH scores were similar between the 2 groups. Conclusions: In this prospective randomized trial, tourniquet release after surgical incision closure resulted in similar clinical outcomes at follow-up when compared with tourniquet release prior to incision closure. In addition, visual analog pain scores and QuickDASH scores were similar between these 2 groups. Surgeons may consider releasing the tourniquet either before or after incision closure when performing upper extremity surgery.
- 10 May 2026
- Published by SAGE Publications in HAND
Timing of Tourniquet Release: A Prospective Randomized Trial
Background: Although the benefits and complications of tourniquet use are well-described, there has been minimal upper extremity research evaluating the timing of tourniquet release and how it affects patient outcomes. The objective of this study was to determine if tourniquet release prior to or after incision closure would affect clinical outcomes in a variety of upper extremity surgeries. Methods: Two hundred fourteen consecutive patients were randomized into 2 groups: skin incision closure without releasing the tourniquet versus skin closure following tourniquet release. Demographic, intraoperative, and follow-up data were collected. Outcome measures included complications such as hematoma formation, Visual Analogue Scores for pain, and Quick Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaires. Results: Two hundred fourteen patients were originally enrolled, with 172 available for follow-up. Ninety-one patients had the tourniquet released prior to incision closure and 81 patients had the tourniquet released after incision closure. Demographic data were similar between the 2 cohorts and there were no intraoperative or immediate postoperative complications requiring intervention in either group. In addition, follow-up data collected including visual analog scores and QuickDASH scores were similar between the 2 groups. Conclusions: In this prospective randomized trial, tourniquet release after surgical incision closure resulted in similar clinical outcomes at follow-up when compared with tourniquet release prior to incision closure. In addition, visual analog pain scores and QuickDASH scores were similar between these 2 groups. Surgeons may consider releasing the tourniquet either before or after incision closure when performing upper extremity surgery.
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
Little League Shoulder and Subsequent Proximal Humeral Fracture in the Setting of Human Growth Hormone Use
Case: A 16-year-old right-hand dominant male baseball player presented with little league shoulder in the setting of recombinant growth hormone utilization for growth hormone deficiency. After a prolonged treatment course, including physical therapy and throwing programs, the patient returned to baseball but suffered an ipsilateral proximal humerus fracture around the growth plate. Conclusion: The occurrence of such an injury in the context of human growth hormone treatment merits consideration in youth athletes undergoing similar treatment regimens. Clinically, we recommend screening pediatric patients with sports-related epiphysiolysis for current or previous growth hormone use because of the possible prognostic implications of such treatment.
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
Little League Shoulder and Subsequent Proximal Humeral Fracture in the Setting of Human Growth Hormone Use
Case: A 16-year-old right-hand dominant male baseball player presented with little league shoulder in the setting of recombinant growth hormone utilization for growth hormone deficiency. After a prolonged treatment course, including physical therapy and throwing programs, the patient returned to baseball but suffered an ipsilateral proximal humerus fracture around the growth plate. Conclusion: The occurrence of such an injury in the context of human growth hormone treatment merits consideration in youth athletes undergoing similar treatment regimens. Clinically, we recommend screening pediatric patients with sports-related epiphysiolysis for current or previous growth hormone use because of the possible prognostic implications of such treatment.